Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.

Probert, Christopher S J

Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. [electronic resource] - Journal of Crohn's & colitis Mar 2014 - 200-7 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1876-4479

10.1016/j.crohns.2013.08.007 doi


Administration, Oral
Administration, Rectal
Adult
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Colitis, Ulcerative--complications
Colonoscopy
Double-Blind Method
Enema
Female
Gastrointestinal Hemorrhage--drug therapy
Humans
Intestinal Mucosa--physiopathology
Male
Mesalamine--administration & dosage
Quality of Life
Rectal Diseases--drug therapy
Severity of Illness Index
Time Factors
Wound Healing--drug effects
Young Adult